Asset Management One
HBIO icon

Asset Management One’s Harvard Bioscience HBIO Stock Holding History

Asset Management One’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,571
Closed -$70K – 1081
2016
Q3 		$70K Hold
2,571
– – ﹤0.01% 1286
2016
Q2 		$74K Hold
2,571
– – ﹤0.01% 1278
2016
Q1 		$78K Hold
2,571
– – ﹤0.01% 1294
2015
Q4 		$89K Hold
2,571
– – ﹤0.01% 1301
2015
Q3 		$97K Hold
2,571
– – ﹤0.01% 1297
2015
Q2 		$147K Hold
2,571
– – ﹤0.01% 1287
2015
Q1 		$150K Hold
2,571
– – ﹤0.01% 1286
2014
Q4 		$146K Hold
2,571
– – ﹤0.01% 1211
2014
Q3 		$105K Buy
+2,571
New +$118K ﹤0.01% 1225

Other funds holding HBIO

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GPC
Glacier Peak Capital Bellevue, Washington $96.2M AUM 0.45% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Asset Management One's HBIO Position: Q4 2016 in Review

Asset Management One sold out of Harvard Bioscience (HBIO) in Q4 2016, closing a stake of 2,571 shares — an estimated $70K sold.

Asset Management One first reported a position in HBIO in Q3 2014 and held it in 9 quarters. The position peaked at $150K in Q1 2015. 68 funds tracked by Wall St. Rank hold HBIO as of Q4 2016.

  • Asset Management One reported no remaining Harvard Bioscience position as of Q4 2016 after selling out during the quarter.
  • Asset Management One sold 2,571 Harvard Bioscience shares in Q4 2016, an estimated $70K.
  • Asset Management One first reported a position in Harvard Bioscience in Q3 2014 and held it in 9 quarters.
  • Asset Management One's Harvard Bioscience position peaked at $150K in Q1 2015.
  • 68 funds tracked by Wall St. Rank held Harvard Bioscience as of Q4 2016.

Based on Asset Management One's 13F filing for Q4 2016, filed 13 Feb 2017.